Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
2.910
+0.210 (7.78%)
At close: Jul 16, 2025, 4:00 PM
2.960
+0.050 (1.72%)
After-hours: Jul 16, 2025, 6:15 PM EDT
Pulmonx Stock Forecast
Stock Price Forecast
The 6 analysts that cover Pulmonx stock have a consensus rating of "Buy" and an average price target of $11.53, which forecasts a 296.22% increase in the stock price over the next year. The lowest target is $4.15 and the highest is $17.
Price Target: $11.53 (+296.22%)
Analyst Consensus: Buy
* Price targets were last updated on May 22, 2025.
Analyst Ratings
The average analyst rating for Pulmonx stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 | 4 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 7 | 7 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Hold Maintains $6.5 → $4.15 | Hold | Maintains | $6.5 → $4.15 | +42.61% | May 22, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $16 → $15 | Strong Buy | Maintains | $16 → $15 | +415.46% | May 1, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $10 → $9 | Buy | Reiterates | $10 → $9 | +209.28% | May 1, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $17 | Strong Buy | Maintains | $17 | +484.19% | May 1, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $17 | Strong Buy | Maintains | $17 | +484.19% | Mar 11, 2025 |
Financial Forecast
Revenue This Year
98.89M
from 83.79M
Increased by 18.02%
Revenue Next Year
116.86M
from 98.89M
Increased by 18.17%
EPS This Year
-1.56
from -1.44
EPS Next Year
-1.44
from -1.56
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 102.4M | 124.2M | 186.6M | ||
| Avg | 98.9M | 116.9M | 145.0M | ||
| Low | 93.6M | 108.2M | 127.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 22.2% | 25.6% | 59.6% | ||
| Avg | 18.0% | 18.2% | 24.1% | ||
| Low | 11.7% | 9.4% | 8.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.56 | -1.24 | -0.90 | ||
| Avg | -1.56 | -1.44 | -1.21 | ||
| Low | -1.55 | -1.52 | -1.43 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.